Pages that link to "Q39001703"
Jump to navigation
Jump to search
The following pages link to Genotyping of Plasmodium falciparum. PCR-RFLP analysis. (Q39001703):
Displaying 20 items.
- Declining responsiveness of Plasmodium falciparum infections to artemisinin-based combination treatments on the Kenyan coast (Q28477892) (← links)
- Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial (Q28542921) (← links)
- Randomized, prospective, three-arm study to confirm the auditory safety and efficacy of artemether-lumefantrine in Colombian patients with uncomplicated Plasmodium falciparum malaria (Q30459470) (← links)
- Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials (Q30592761) (← links)
- Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance (Q33645352) (← links)
- Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology (Q34221842) (← links)
- Genetic diversity of Plasmodium falciparum among school-aged children from the Man region, western Côte d'Ivoire (Q35042596) (← links)
- Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study (Q35218484) (← links)
- Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs (Q36314347) (← links)
- Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial (Q36594406) (← links)
- The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea (Q36649305) (← links)
- Heterogeneous distribution of Plasmodium falciparum drug resistance haplotypes in subsets of the host population (Q36667585) (← links)
- The risk of malarial infections and disease in Papua New Guinean children. (Q37088901) (← links)
- Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness (Q37099503) (← links)
- FlexiChip package: an universal microarray with a dedicated analysis software for high-thoughput SNPs detection linked to anti-malarial drug resistance (Q37405832) (← links)
- Critical Evaluation of Molecular Monitoring in Malaria Drug Efficacy Trials and Pitfalls of Length-Polymorphic Markers (Q37538733) (← links)
- Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis (Q38895510) (← links)
- Antigenic cross-reactivity between different alleles of the Plasmodium falciparum merozoite surface protein 2. (Q39001696) (← links)
- Optimization and validation of multi-coloured capillary electrophoresis for genotyping of Plasmodium falciparum merozoite surface proteins (msp1 and 2) (Q42155400) (← links)
- Malaria parasite clearance from patients following artemisinin-based combination therapy in Côte d'Ivoire (Q59126227) (← links)